Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Novaliq GmbH Exclusive Interview ReleasedOphthalmic Drugs Interviews Co-Founder, Chief Innovation Officer, Novaliq GmbH
By: SMi Group Bernhard Guenther is the Co-Founder and Chief Innovation Officer at Novaliq. Before taking over the CIO position at the end of last year, he served for 12 years as the CEO of the company. As the CIO he is responsible for the identification and evaluation of new, early-stage development candidates regarding their potential to become part of Novaliq's innovative product pipeline. Hear more from Bernhard at Ophthalmic Drugs 2017 as he presents: 'Aqueous, preservative- Gain insight into EyeSol Technology, non-aqueous, preservative- For those looking to attend there is currently a £300 early-bird saving! Further information is available at: www.ophthalmicdrugs.com/ SMi Presents the Launch of… Ophthalmic Drugs Date: 28th – 29th November 2017 Location: Kensington, London Website: www.ophthalmicdrugs.com/ Sponsored by: Leica Microsystems | Experimentica ---end--- Contact Information: For all media inquiries contact Pavan Solanki on Tel: +44 (0)20 7827 6048 / Email: psolanki@smi- About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to- End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|